UNI MEDICAL keeps issued shares steady at 2.01 billion in March 2026, confirms 25%+ public float

Bulletin Express04-02

Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, showing no changes in share capital structure.

The company closed the month with 2.01 billion ordinary shares in issue and zero treasury shares, identical to the preceding month.

UNI MEDICAL confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least the 25% threshold of freely tradable shares.

The Share Option Scheme, approved on 31 December 2019, recorded no outstanding options at month-end and generated no share issuances or cash inflows in March. Up to 155.57 million shares remain available for future option grants under the scheme.

There were no warrants, convertible securities, depositary receipts, or other share-issuance arrangements in effect, and the company executed no share repurchases or cancellations during the month.

The filing, authorised by Executive Director Chen Shisu, also attests that all regulatory and listing-rule obligations related to the company’s securities continue to be met.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1169184713?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 17:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169184713","market":"us","top_or_hot":-1,"title":"UNI MEDICAL keeps issued shares steady at 2.01 billion in March 2026, confirms 25%+ public float","media":"Bulletin Express","content":"<p>Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, showing no changes in share capital structure.</p>\n<p>The company closed the month with 2.01 billion ordinary shares in issue and zero treasury shares, identical to the preceding month.</p>\n<p>UNI MEDICAL confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least the 25% threshold of freely tradable shares.</p>\n<p>The Share Option Scheme, approved on 31 December 2019, recorded no outstanding options at month-end and generated no share issuances or cash inflows in March. Up to 155.57 million shares remain available for future option grants under the scheme.</p>\n<p>There were no warrants, convertible securities, depositary receipts, or other share-issuance arrangements in effect, and the company executed no share repurchases or cancellations during the month.</p>\n<p>The filing, authorised by Executive Director Chen Shisu, also attests that all regulatory and listing-rule obligations related to the company’s securities continue to be met.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UNI MEDICAL keeps issued shares steady at 2.01 billion in March 2026, confirms 25%+ public float</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUNI MEDICAL keeps issued shares steady at 2.01 billion in March 2026, confirms 25%+ public float\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 17:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, showing no changes in share capital structure.</p>\n<p>The company closed the month with 2.01 billion ordinary shares in issue and zero treasury shares, identical to the preceding month.</p>\n<p>UNI MEDICAL confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least the 25% threshold of freely tradable shares.</p>\n<p>The Share Option Scheme, approved on 31 December 2019, recorded no outstanding options at month-end and generated no share issuances or cash inflows in March. Up to 155.57 million shares remain available for future option grants under the scheme.</p>\n<p>There were no warrants, convertible securities, depositary receipts, or other share-issuance arrangements in effect, and the company executed no share repurchases or cancellations during the month.</p>\n<p>The filing, authorised by Executive Director Chen Shisu, also attests that all regulatory and listing-rule obligations related to the company’s securities continue to be met.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02666","symbol_name":"环球医疗","start_time":0,"source_url":"","article_id":"1169184713","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169184713","pubTimestamp":1775120834,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, showing no changes in share capital structure. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02666":"环球医疗"},"translate_title":"Uni Medical 2026年3月已发行股份稳定在20.1亿股，确认公众持股量超过25%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02666":1},"content_text":"Genertec Universal Medical Group Company Limited (UNI MEDICAL) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, showing no changes in share capital structure.\nThe company closed the month with 2.01 billion ordinary shares in issue and zero treasury shares, identical to the preceding month.\nUNI MEDICAL confirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least the 25% threshold of freely tradable shares.\nThe Share Option Scheme, approved on 31 December 2019, recorded no outstanding options at month-end and generated no share issuances or cash inflows in March. Up to 155.57 million shares remain available for future option grants under the scheme.\nThere were no warrants, convertible securities, depositary receipts, or other share-issuance arrangements in effect, and the company executed no share repurchases or cancellations during the month.\nThe filing, authorised by Executive Director Chen Shisu, also attests that all regulatory and listing-rule obligations related to the company’s securities continue to be met.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169184713","isCrawlerRequest":true}